NCT00416637 2016-07-07Bevacizumab in Treating Patients With Advanced Solid TumorsDuke UniversityPhase 1 Completed27 enrolled
NCT00276575 2014-11-19Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid TumorsDuke UniversityPhase 1 Completed65 enrolled